Back to Trials
NCT06735027NARecruiting

Corticosteroid Injection Versus Nerve Block

University of Minnesota

Start Date

1/2/2025

Completion Date

1/2/2027

Summary

The purpose of this study is to evaluate conservative pain relief measures for patients suffering from glenohumeral arthritis or rotator cuff arthropathy. Conservative management of osteoarthritis is often first line treatment, and while a corticosteroid injection is frequently used, suprascapular nerve blocks have not often been described as an analgesic option in this population.

Eligibility Criteria

Age Range: 18 years to 99 years

Inclusion Criteria: * diagnosis of glenohumeral osteoarthritis, rheumatoid arthritis, or rotator cuff arthropathy who are being offered injection Exclusion Criteria: * uncontrolled diabetes (patients will be excluded if no HbA1c within a year or if it is 8 or greater" * known allergy to steroid or anesthetic * pregnant women * prisoners * patients with diminished capacity to consent to participation * children under 18 years of age * non-English speakers

Interventions

OTHER

intraarticular corticosteroid injection (IACI)

OTHER

suprascapular nerve block (SSNB)

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Glenohumeral ArthritisRotator Cuff Arthropathy

Locations

University of Minnesota

Minneapolis, Minnesota 55414

United States